Angina Pectoris clinical trials

Explore recruiting angina pectoris clinical trials.

Recruiting angina pectoris studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Angina Pectoris trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Vericiguat in Vasospastic Angina (ViVA)

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A Randomized, Double-blind, Placebo-controlled, Three-arm Parallel-group, Multi-centre Phase III Clinical Study to Confirm the Anti-anginal Effect of T89 in Patients with Stable Angina (ORESA Study)

Bulgaria, Slovakia, Romania, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

A single-dose, randomized, two-period, two-sequence, crossover pilot bioequivalence study on formulations containing rivaroxaban and acetylsalicylic acid in healthy volunteers under fasting conditions.

Czechia

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

Endocardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment: A 26-Week (with 26 Week Extension) Phase 2b Randomized, Multi-Center, Double-Blind, Sham Controlled Study to Evaluate Efficacy and Safety (EXACT-2 Trial)

Belgium, Poland, Hungary, Netherlands, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Multimodal METformin and FINGER lifestyle intervention to prevent cognitive impairment and disability in older adults at risk for dementia: a phase IIb multi-national randomised, controlled trial.

Sweden, Finland

Therapeutic exploratory (Phase II) EU CTIS Study details

Beta-blockeRs tO patieNts with CHronIc Obstructive puLmonary diseasE (BRONCHIOLE)

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

Angina Pectoris trials by city

Angina Pectoris in Toronto Angina Pectoris in Vancouver Angina Pectoris in Montreal Angina Pectoris in Calgary Angina Pectoris in Edmonton Angina Pectoris in Ottawa Angina Pectoris in Winnipeg Angina Pectoris in Quebec City Angina Pectoris in Hamilton Angina Pectoris in Kitchener Angina Pectoris in London Angina Pectoris in Halifax Angina Pectoris in New York Angina Pectoris in Los Angeles Angina Pectoris in Chicago Angina Pectoris in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease